Top 8 Meningococcal Vaccines Companies in the World

The global meningococcal vaccines market size reached US$ 3.6 Billion in 2023. As per the analysis by IMARC Group, the top meningococcal vaccines companies are heavily investing in various product innovations, such as the development of ready-to-use liquid formulations, which do not require reconstitution. Moreover, the governments of several countries are implementing vaccination programs to protect their population against meningococcal disease, further supporting the leading companies. Additionally, the governments are launching extensive public health programs while emphasizing the immunization of special risk groups, such as tourists and military personnel, to contain the risks of infections, which, in turn, is strengthening the market. In line with this, various non-profit organizations and private companies are investing in the research and development of new and improved meningococcal vaccines, which is fuelling the growth of the industry. Along with this, several leading companies are collaborating with vaccine manufacturers, governments, and other stakeholders for the development and distribution of meningococcal vaccines. Apart from this, the increasing health consciousness among the masses and the adoption of routine immunization are catalyzing the growth of the market. Besides, the growing adoption of the combination vaccine is augmenting the market as these vaccines provide protection against meningococcal diseases. Furthermore, continual technological advancements in vaccine development, manufacturing, and delivery are creating a positive market outlook. Other factors, such as a rising focus on disease eradication, growing demand for personalized medicine, rising demand for booster doses, and improvements in the healthcare infrastructure, are projected to propel the market further. On account of these factors, the market to reach US$ 7.2 Billion by 2032, exhibiting a growth rate (CAGR) of 7.7% during 2024-2032.

Learn about opportunities, challenges, and trends in the global Meningococcal Vaccines market with IMARC’s market research report. Try a free sample today!

List of Top Companies Operating in the Meningococcal Vaccines  Industry:

The global meningococcal vaccines market has several major players GlaxoSmithKline Plc, Hualan Biological Engineering Inc., Incepta Pharmaceuticals Limited, Novartis AG, Pfizer Inc., Sanofi S.A., Serum Institute of India Ltd., and Walvax Biotechnology Co. Ltd. More information about these companies has been provided below.

1. GlaxoSmithKline Plc

GlaxoSmithKline Plc (GSK) is a British multinational pharmaceutical company that operates in pharmaceuticals, vaccines, and consumer healthcare. Its product portfolio includes Shingrix, Boostrix, Advair, Nucala, Voltaren, Sensodyne, and Triumeq. It has a strong focus on research and development and heavily invests in innovation to introduce new products to the market. The company is also exploring new drug delivery methods, such as inhalers and injectable treatments. It has developed vaccines for a range of infectious diseases, including influenza, meningitis, and HPV. Besides, the company is investing in renewable energy and energy-efficient technologies to reduce its carbon footprint. Additionally, it has a code of conduct that outlines its commitment to responsible business practices, such as anti-bribery and anti-corruption measures.

2. Hualan Biological Engineering Inc.

Hualan Biological Engineering Inc. is a Chinese biopharmaceutical company that is engaged in the research, development, manufacturing, and sale of biologics. The company offers vaccines for human use, such as influenza, hepatitis A and B, meningococcal, pneumococcal, and rabies vaccines, and a range of biological products for animal use, such as swine fever, avian influenza, and foot-and-mouth disease vaccines. It is committed to improving the health of individuals by providing safe and effective vaccines and biological products. The company is also committed to reducing its environmental footprint and promoting sustainable development. Additionally, it has implemented several measures to reduce energy consumption, water usage, and waste generation in its operations.

3. Incepta Pharmaceuticals Limited

Incepta Pharmaceuticals Limited is a leading pharmaceutical company. Its product portfolio includes antibiotics, cardiovascular drugs, anti-diabetic agents, anti-ulcerants, and anti-cancer agents. It is dedicated to improving access to quality healthcare and is committed to making a positive impact on the lives of individuals across the globe. The company has a strong focus on innovation and heavily invests in research and development to bring new and innovative pharmaceutical products to the market. It has developed a range of extended-release formulations for several of its products, which allow for once-daily dosing and improved patient compliance. Besides, the company is also investing in renewable energy sources, such as solar power, to reduce its carbon footprint.

4. Novartis AG

Novartis AG is a multinational pharmaceutical company that offers a wide range of products across various therapeutic areas, such as oncology, cardiovascular, respiratory, neuroscience, ophthalmology, and immunology. Its product portfolio includes Afinitor, Entresto, Lucentis, Cosentyx, and Gilenya. The company has made significant investments in digital technology, data analytics, and artificial intelligence to accelerate drug discovery and improve patient outcomes. It is also committed to sustainability and has set ambitious targets to reduce its environmental impact and increase access to healthcare in underserved communities. Besides, the company has established several programs to increase access to essential medicines, improve healthcare infrastructure, and provide healthcare education and training.

5. Pfizer Inc.

Pfizer Inc. is a leading global pharmaceutical company that focuses on discovering, developing, and manufacturing innovative medicines and vaccines. It offers Lipitor, Viagra, Lyrica, and Pfizer-BioNTech. The company is committed on conducting its business in a responsible and ethical manner and has established numerous initiatives to promote sustainability, corporate responsibility, and transparency. It has established several initiatives to provide free or low-cost medicines to individuals in need. The company has established several programs to support healthcare and education initiatives, including the Pfizer foundation and the global health fellows program. Besides, it has developed several treatments for rare diseases, including tafamidis for transthyretin amyloidosis and Vyndaqel for familial amyloid polyneuropathy.

6. Sanofi S.A.

Sanofi S.A. is a multinational pharmaceutical company that focuses on researching, developing, manufacturing, and marketing pharmaceutical products for the treatment of a wide range of medical conditions. It offers medicines for diabetes, cardiovascular diseases, oncology, rare diseases, vaccines, and over-the-counter medications. The company heavily invests in research and development, with the goal of developing innovative therapies and treatments for patients in need. It is committed to sustainability and corporate social responsibility. The company focusses to minimize its environmental impact, promote diversity and inclusion, and support access to healthcare in underserved communities. It also supports sustainable agriculture practices and has launched a program to promote sustainable farming.

7. Serum Institute of India Ltd.

The Serum Institute of India Ltd. (SII) is a pharmaceutical company that develops affordable vaccines and drugs. The company offers vaccines for measles, mumps, rubella, polio, influenza, rotavirus, meningococcal disease, and COVID-19. Its product line includes Covovax, Rotasiil, MMR vaccine, Rabishield, and Influenza vaccine. The company has implemented innovative cold chain management practices to ensure that vaccines remain effective during transportation and storage. Besides, it has implemented a waste management program to reduce the amount of waste generated by its manufacturing operations. Additionally, the company has implemented several water conservation initiatives to reduce its water consumption. It has also implemented several community development programs, including education and healthcare initiatives, and has supported local environmental conservation projects.

8. Walvax Biotechnology Co. Ltd.

Walvax Biotechnology Co. Ltd. is a biopharmaceutical company that focuses on the research and development of vaccines and other immunological products. It offers immunological diagnostic reagents, including ELISA kits and rapid diagnostic test kits, and biopharmaceutical products, including cytokines, monoclonal antibodies, and other immunomodulators. The company is committed to social responsibility and has implemented a number of initiatives to improve public health, such as donating vaccines and providing training to medical professionals. Besides, it has developed several innovative vaccines, including a quadrivalent influenza vaccine, a meningococcal polysaccharide conjugate vaccine, and a pneumococcal polysaccharide conjugate vaccine, that have helped to address unmet medical needs and improve public health outcomes.

About Author: